Updated: May 19, 2026

Steven lo

VXRTVaxart, Inc.SEC CIK: 0001501959
Estimated Net Worth
$19.3 Million0.0%vs Last Year
Last Updated: May 19, 2026 03:42 AM EST

Transaction Summary

Total Transactions44
Buy-Sell Ratio0.08
Buy Transactions1
Sell Transactions13

Transaction Volume

Total Volume-$950.51K
Net Volume$1.05M
Buy Volume$49.00K
Sell Volume-$999.51K

Trade Analysis

AVG Trade Size$88.89K
Largest Trade$3.59M
Most Active MonthMar
Most Active Year2015

Trading Sentiment

OverallBullish
Recent TradeNeutral
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Steven lo has an estimated net worth of $19.3 Million. This is based on reported shares across multiple companies, which include CORCEPT THERAPEUTICS INC, Zosano Pharma Corp, PUMA BIOTECHNOLOGY, INC., and Vaxart, Inc..



2015 was Steven lo's most active year for acquiring shares with 15 total transactions. Steven lo's most active month to acquire stocks was the month of October. 2015 was Steven lo's most active year for disposing of shares, totalling 5 transactions. Steven lo's most active month to dispose stocks was the month of December. 2010 saw Steven lo paying a total of $1,404,000.00 for 400,000 shares, this is the most they've acquired in one year. In 2015 Steven lo cashed out on 229,166 shares for a total of $754,285.16, their largest year based on trade value.

Holdings & Transactions

VXRTvaxart, inc.
President, Chief Exec Officer Director
Updated: Mar 26, 2026VIEW QUOTE
Form TypeSEC Filing
-0.05126.03K$0.69-$87.46K2.59MMar 24View
-0.0122.43K$0.63-$14.23K2.71MMar 18View
1.342.39M4.28MMar 16View
0.0697.20K$0.37-$20.04K1.89MDec 04View
100.00K$0.49$49.00K100.00KMay 19View
15.433.51M3.74MMar 24View
-0.0922.36K$0.57-$12.75K227.64KMar 18View
1.25M1.25MMar 18View
View
zosano pharma corp
Chief Executive Officer Director
Updated: Jun 07, 2022
Form TypeSEC Filing
-0.03442.00$0.71-$313.8213.16KJun 06View
-0.0523.63K$0.21-$4.97K460.71KMar 31View
0.97356.25K721.84KOct 15View
-0.0313.16K$0.81-$10.59K365.59KJun 04View
4.77697.50K843.75KMar 30View
450.00K450.00KMar 18View
146.25K146.25KJun 25View
292.50K292.50KJun 03View
450.00K450.00KOct 21View
View
PBYIpuma biotechnology, inc.
Chief Commercial Officer Officer
Updated: Jul 24, 2019VIEW QUOTE
Form TypeSEC Filing
-0.091.85K$10.04-$18.60K19.56KScheduledJul 22View
36.30K36.30KFeb 06View
-0.092.11K$24.91-$52.66K21.41KScheduledJan 22View
-0.071.84K$51.85-$95.36K23.52KScheduledJul 20View
33.00K33.00KFeb 11View
-0.071.86K$92.85-$172.52K25.36KScheduledJan 22View
-0.071.99K$94.90-$188.85K27.22KScheduledJul 20View
31.50K31.50KFeb 16View
-0.072.29K$33.24-$76.11K29.21KScheduledJan 20View
31.50K31.50KOct 14View
30.00K30.00KMay 25View
150.00K150.00KSep 08View
View
CORTcorcept therapeutics inc
SVP Oncology Officer
Updated: Nov 16, 2015VIEW QUOTE
Form TypeSEC Filing
1.17M$2.91$3.59M585.42KNov 16View
12.50K$3.47$32.25K12.50KOct 26 - 02View
-1.0053.03K$3.82-$202.59KOct 13View
-0.095.30K$4.00-$21.20K53.03KOct 07View
-0.4650.00K$3.76-$188.00K58.33KOct 06View
$2.70141.67KSep 29View
100.00K100.00KFeb 18View
200.00K200.00KNov 19View
100.00K100.00KJan 30View
200.00K200.00KOct 10View
400.00K$3.51$1.40M400.00KSep 24View
View